Thoma Bravo, the private equity firm based in the United States, has completed its merger with Hypergene, a provider of technology solutions for financial planning and governance based in Norway and Sweden. The deal was finalized on July 7, 2026.

Deal-at-a-Glance
AcquirerThoma Bravo (US)
TargetHypergene (NO / SE)
Type of DealMerger
Closing Date2026-07-07
Deal ValueUndisclosed
Buy-side AdvisorsMoeilis, The Raine Group, Grant Thornton
Sell-side AdvisorsAicardi & Partners
Legal Buy-sideHirschler, Setterwalls Advokatbyrå
Legal Sell-sideHirschler

Rationale Behind the Deal

The merger aims to establish a leading provider of comprehensive technology solutions in connected financial planning, performance and enterprise governance. By combining Hypergene's strengths with Thoma Bravo’s strategic investment expertise, the new entity seeks to expand its market presence and enhance service offerings.

Financial Context

The deal is part of a broader trend within the technology sector towards consolidation in financial software services. The merger will position the combined company as a formidable competitor in the Nordic region's fast-growing SaaS (Software-as-a-Service) market.

Advisors to the Transaction

Moeilis and The Raine Group provided financial advisory services, while Grant Thornton offered strategic advice on the buy-side. Aicardi & Partners represented Hypergene on the sell-side. Legal representation was handled by Hirschler for both parties.

Outlook

The combined entity is expected to leverage synergies from its merged operations to accelerate innovation and scale up its offerings across Europe and beyond. The transaction also highlights Thoma Bravo's ongoing commitment to the technology sector, especially in areas with high growth potential.